Trials / Sponsors / Banner Life Sciences LLC
Banner Life Sciences LLC
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice Relapsing Remitting Multiple Sclerosis | — | 2023-08-17 |
| Withdrawn | Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimeth Relapsing Remitting Multiple Sclerosis | — | 2021-06-30 |
| Completed | Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subj Relapsing Remitting Multiple Sclerosis | Phase 1 | 2021-05-14 |
| Completed | Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteer Multiple Sclerosis | Phase 1 | 2019-07-07 |
| Completed | Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Relapsing Remitting Multiple Sclerosis | Phase 1 | 2017-01-06 |